Form 8-K · Current Report · Filed 2025-04-28
Pfizer Inc. Announces Results of Annual Meeting of Shareholders
Pfizer Inc. announced the results of its Annual Meeting of Shareholders held on April 24, 2025. Shareholders elected all nominees for the Board of Directors, ratified the selection of KPMG LLP as the independent registered public accounting firm, approved the 2025 compensation of the Company's Named Executive Officers on an advisory basis, and rejected two shareholder proposals: 'Adopt Shareholder Vote Regarding Golden Parachutes' and 'Issue A Report Evaluating The Risks Related To Religious Discrimination Against Employees'.
- Filer
- Pfizer Inc. PFE · NYSE
- Filed
- Accession
- 0000078003-25-000109
- CIK
- 0000078003
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Submission of Matters to a Vote of Security Holders
Market reaction
Close before filing
$22.92
Next session
+3.8%
Since filing
+9.1%
Latest close
$25.01
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from PFE reporting the same item, with the next session's move:
About Pfizer Inc.
Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation, recognized for its role in the research, development, and manufacturing of healthcare products. Operating in the health sector, Pfizer focuses on creating innovative medicines and vaccines that significantly improve patients' lives. It is renowned for its contributions to pivotal health areas, such as oncology, immunology, cardiovascular health, and rare diseases. Pfizer maintains a robust pipeline of products at various stages of clinical development, enhancing its market position and impact. The company is instrumental in the global pharmaceutical landscape, contributing to public health with breakthroughs like vaccines and therapies that tackle some of the world's most challenging diseases. Headquartered in New York City, Pfizer plays a critical role in addressing urgent medical needs worldwide and is involved in extensive collaborations with scientific communities and healthcare systems. As a key player in the pharmaceutical industry, Pfizer’s developments and strategic initiatives can influence market trends and health policies, underscoring its importance in the global effort to combat health issues.
Never miss another PFE filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.